Document is current

Any future updates will be listed below

Correction: Evaluation of Safety, Pharmacokinetic, and Pharmacodynamic Characteristics of a Novel Dual mGluR5/5‑HT2AR Antagonist (VVZ‑2471) in a Randomized, Double‑Blind, First‑in‑Human Study

Crossref DOI link: https://doi.org/10.1007/s40263-026-01279-8

Published Online: 2026-02-26

Published Print: 2026-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark